Cargando…
Microencapsulation of cells and molecular therapy of type 1 diabetes mellitus: The actual state and future perspectives between promise and progress
The history of microencapsulation of live cells started with an idea of Thomas MS Chang in 1964, thereafter applied to isolated pancreatic islets by Anthony M Sun in 1980. The original aim was to provide isolated cells with an immune‐protective shield, to prevent physical contact between the transpl...
Autores principales: | Basta, Giuseppe, Montanucci, Pia, Calafiore, Riccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926256/ https://www.ncbi.nlm.nih.gov/pubmed/32700473 http://dx.doi.org/10.1111/jdi.13372 |
Ejemplares similares
-
Human induced pluripotent stem cells (hiPSC), enveloped in elastin-like recombinamers for cell therapy of type 1 diabetes mellitus (T1D): preliminary data
por: Montanucci, Pia, et al.
Publicado: (2023) -
Long-Term Metabolic and Immunological Follow-Up of Nonimmunosuppressed Patients With Type 1 Diabetes Treated With Microencapsulated Islet Allografts: Four cases
por: Basta, Giuseppe, et al.
Publicado: (2011) -
The role behind the scenes of Tregs and Th17s in Hashimoto’s thyroiditis: Toward a pivotal role of FOXP3 and BACH2
por: Mazzieri, Alessio, et al.
Publicado: (2022) -
Emerging of a new CD3(+)CD31(H)CD184(+) tang cell phenothype in Sjögren’s syndrome induced by microencapsulated human umbilical cord matrix-derived multipotent stromal cells
por: Montanucci, Pia, et al.
Publicado: (2023) -
Microencapsulation for cell therapy of type 1 diabetes mellitus: The interplay between common beliefs, prejudices and real progress
por: Calafiore, Riccardo
Publicado: (2018)